Pharma Conversation & Community
A round up of news from across the web, including trends from social social media platforms.
HITTING THE HEADLINES
FDA Issues Draft Guidance on Electronic Submissions
FDA has issued a draft guidance, Guidance for Industry: Providing Submissions in Electronic Format—Summary Level Clinical Site Data for CDER's Inspection Planning, which is one in a series of documents intended to assist sponsors and applicants making certain regulatory submissions to FDA in electronic format.
PharmTech.com/ElectronicGuidance
US Supreme Court to Hear Pay-for-Delay Case
The US Supreme Court agreed to hear a case that will decide whether brand-name drug companies may pay generic drug-companies to delay introduction of lower-cost generic drugs. The Supreme Court is to review a federal appeals court ruling that upheld a "pay-for-delay" arrangement.
Ranbaxy Recalls Atorvastatin Due to Quality Issues
Ranbaxy Pharmaceuticals is recalling certain lots of its atorvastatin tablets because of possible contamination with small glass particles (less than 1 mm in size). Ranbaxy has ceased atorvastatin manufacturing until it has thoroughly investigated the problem.
INDUSTRY M&As
- Valeant Pharmaceuticals International has completed its acquisition of Medicis Pharmaceutical.
- Isochem has expanded its range of intermediates by acquiring the British fine-chemicals company, Wychem.
- French contract manufacturing firm Synerlab has acquired lyophilization specialist company Lyofal.
- Amgen has agreed to buy Icelandic-based Decode Genetics for $415 million in an all-cash transaction.
SEEKING INPUT
PharmTech is seeking reader input for a future feature on parenteral drug manufacturing. Send your questions and thoughts to the Community Manager, Stephanie Sutton, at ssutton@advanstar.com.
READERS THINK THAT...
Take part in our latest poll at: PharmTech.com/Polls
ON THE BLOG
"Real-time devices for continuous feeding processes were discussed at a seminar I recently attended."
Jennifer Markarian, PharmTech.com/RealTime
See more posts at blog.PharmTech.com
MOST TWEETED
- Pharma companies using new analytical methods to ensure quality of medicine ht.ly/g0oIm
- How to optimize continuous processing and make it work in pharmaceutical manufacturing is a crucial issue. ht.ly/g4AtD
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
